13F Pro quality score
Rank #2,860 of 2,925
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
CERENOME, INC. (CNSY) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CNSY at 11.5/100 on a composite quality score built from its SEC filings, placing it at rank #2,860 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), CERENOME, INC. reports quarterly revenue of $411.0K, net income of $-9.0M, free cash flow of $-7.6M. Top institutional holders of CNSY by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, BlackRock, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. CNSY trades on the Nasdaq exchange and files with the SEC under CIK 1095981. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CNSY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CERENOME, INC. directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1095981 →